Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amimestrocel (umbilical cord mesenchymal stem cell) infusion for aging
ChiCTR2600125012Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of amimestrocel in Ageing (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Biological age alterations derived from multimodal data models. Planned start May 2026; status: not yet recruiting.
02
Drugs
amimestrocel
03
Conditions
Ageing
Beyond the preview
Go deeper on ChiCTR2600125012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125012.